These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29448306)

  • 1. ALBI versus Child-Pugh grading systems for liver function in patients with hepatocellular carcinoma.
    Na SK; Yim SY; Suh SJ; Jung YK; Kim JH; Seo YS; Yim HJ; Yeon JE; Byun KS; Um SH
    J Surg Oncol; 2018 Apr; 117(5):912-921. PubMed ID: 29448306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma.
    Carling U; Røsok B; Line PD; Dorenberg EJ
    Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma.
    Kornberg A; Witt U; Schernhammer M; Kornberg J; Müller K; Friess H; Thrum K
    J Surg Oncol; 2019 Dec; 120(7):1126-1136. PubMed ID: 31578753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
    Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ability of the ALBI grade to predict posthepatectomy liver failure and long-term survival after liver resection for different BCLC stages of HCC.
    Zhang ZQ; Xiong L; Zhou JJ; Miao XY; Li QL; Wen Y; Zou H
    World J Surg Oncol; 2018 Oct; 16(1):208. PubMed ID: 30326907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
    Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX
    Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
    Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
    Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
    Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
    Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.
    Johnson PJ; Berhane S; Kagebayashi C; Satomura S; Teng M; Reeves HL; O'Beirne J; Fox R; Skowronska A; Palmer D; Yeo W; Mo F; Lai P; Iñarrairaegui M; Chan SL; Sangro B; Miksad R; Tada T; Kumada T; Toyoda H
    J Clin Oncol; 2015 Feb; 33(6):550-8. PubMed ID: 25512453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
    Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK; Song MJ; Kim SH; Park M
    PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Modified Child-pugh (MCP), Albumin-bilirubin (ALBI), and Child-pugh (CP) score for predicting of survival in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization.
    Liu Y; Cheng C; Zhou H; Hu S; Wang H; Xie Q; Lei L; Wang P; Liu G; Hu H
    Bull Cancer; 2021 Oct; 108(10):931-939. PubMed ID: 34247763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
    Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
    J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
    Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.
    Chan AW; Kumada T; Toyoda H; Tada T; Chong CC; Mo FK; Yeo W; Johnson PJ; Lai PB; Chan AT; To KF; Chan SL
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1300-6. PubMed ID: 26751608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.